/Investor DB

Viking Global Investors — 2019 Investments

4 investments dated 2019 · listed companies and verified rows first · show all

Auris Healthaurishealth.comJan 2019 · $220M

Developer of a surgical robotic system for minimally invasive endoscopy and laparoscopy

Frederic Moll(Founder)

Co-investorsBeast VenturesLux CapitalMithril Capital ManagementPractica CapitalSBI Investment Korea Co. Ltd.Sonder Capital+5 more

Checkerspotcheckerspot.cominApr 2019 · $13M

Checkerspot uses microalgae precision fermentation to produce specialized lipids and fats, including a bio-equivalent source of the sn-2 palmitate fat found in mother's milk, rare bioactive fatty acids, and tropical fat alternatives.

BiotechClimate TechFoodTechNew MaterialsAlameda, US

Scott Franklin(Executive Officer, Director)inCharles Dimmler(Executive Officer, Director)inJohn Krzywicki(CEO)inLayla Ward(CFO)inCasey Lippmeier(CTO)inLeon Parker(SVP, Molecular Biology)in

Co-investorsBaruch Future VenturesBreakout VenturesCavallo VenturesKdT VenturesPlug and Play VenturesViking Global+5 more

Druvadruva.comin𝕏Jun 2019 · $147M

Druva provides a cloud-native SaaS platform for data backup, protection, recovery, and AI-driven data insights across enterprise data and workloads.

Cloud ComputingCybersecuritySaaSSunnyvale, US

Milind Borate(Founder)inJaspreet Singh(Founder)inMahesh Patel(Executive Officer)inEugenia Buzogly(Executive Officer)Ramani Kothandaraman(Founder)

BoardShailendra Jit Singh(Director)in

Co-investorsArbor Ventures UKDell Technologies CapitalFounders Circle CapitalHercules Capital, Inc.IAN GroupLightspeed India Partners+12 more

Kinnate Biopharmakinnate.comDec 2019

BiotechSan Diego, US

Stephen W. Kaldor(Executive Officer, Director, Promoter)Eric Murphy(Executive Officer, Director)

BoardBret Zbar(Director)Carl Gordon(Director)Michael Rome(Director)in

Co-investorsForesite CapitalNextech InvestViking GlobalJanus Henderson InvestorsRA CapitalVenrock Healthcare Capital Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.